Increased tumour weight (Fig. 1c) and cell proliferation (Ki-67; Fig. 1d) were evident by 36 weeks of age in the HFD-fed mice compared to the CTD group, confirming previous reports that HFD significantly enhances the progression of MYC-driven prostate cancer10,11. The gene discussed is MYC; the disease is neoplasm.